Catalyst Wire Dossier Catalyst Wire Dossier

SCOPOLAMINE TRANSDERMAL SYSTEM

scopolamine transdermal system · Padagis Israel Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SCOPOLAMINE TRANSDERMAL SYSTEM, covering 2015-01-30 to 2026-02-09. Get the full timeline:

Most recent: FDA Approved: SCOPOLAMINE TRANSDERMAL SYSTEM — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

See pricing